Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Jerome Canady Research Institute For Advanced Biological And Technological Sciences Benefit LLC has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. Examiner BROWN, KYLE MARTZ is the busiest examiner for the institute, currently managing this 1 pending action.
The prosecution footprint is limited to 1 distinct examiner and 1 distinct art unit. This concentration suggests that the institute's current patenting efforts are focused on a specific technical niche within the Medical Devices & Mechanical Engineering field, managed by a single examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLS, LAUREN QUINLAN | 1 | 48.4% | +60.3% |
| TRAN, KHOA NHAT | 1 | 43.2% | +53.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18195223 | COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY | TRAN, KHOA NHAT | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18195223 | COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY | TRAN, KHOA NHAT | 33d |
| 18782803 | METHOD FOR TREATMENT OF CANCER WITH COMBINATION OF COLD ATMOSPHERIC PLASMA AND A GENE INHIBITOR | WELLS, LAUREN QUINLAN | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18782803 | METHOD FOR TREATMENT OF CANCER WITH COMBINATION OF COLD ATMOSPHERIC PLASMA AND A GENE INHIBITOR | WELLS, LAUREN QUINLAN | — | §112DP | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18195223 | COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY | TRAN, KHOA NHAT | 1632 | §103§112 | Non-Final OA | 33d | Pending | May 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial